Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026)
Coya Therapeutics (COYA) posted Asset Utilization Ratio of 0.15 for Q1 2026, down 20.63% sequentially from 0.19 in Q4 2025, and up 72.71% YoY from 0.09 in Q1 2025.
Coya Therapeutics (COYA) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
Coya Therapeutics has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.15 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 72.71% year-over-year to 0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.15 (up 72.71% YoY) and the FY2025 annual result came in at 0.17, up 102.97% from the prior year.
- Asset Utilization Ratio eased to 0.15 in Q1 2026 per COYA's latest filing, from 0.19 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.25 in Q3 2024 and troughed at 0.01 in Q2 2025.
- A 4-year average of 0.15 and a median of 0.15 in 2024 frame the typical range for Asset Utilization Ratio.
- The widest YoY moves for Asset Utilization Ratio: up 117.86% in 2025, down 95.23% in 2025.
- Over 4 years, Asset Utilization Ratio stood at 0.23 in 2023, then slumped by 60.61% to 0.09 in 2024, then surged by 117.86% to 0.19 in 2025, then declined by 20.63% to 0.15 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.15, 0.19, and 0.12 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.13 |
| 10 | Coya Therapeutics | 114.24 Mn | 71.04 Mn | - | 0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.16 |
| Mar 31, 2026 | 0.15 |
| Dec 31, 2025 | 0.19 |
| Sep 30, 2025 | 0.12 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.25 |
| Jun 30, 2024 | 0.25 |
| Mar 31, 2024 | 0.16 |
| Dec 31, 2023 | 0.23 |